|
|
Volumn 65, Issue 4, 2015, Pages 402-404
|
|
Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: An analysis from TNT and IDEAL
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PLACEBO;
SIMVASTATIN;
TRIACYLGLYCEROL;
BODY MASS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIET RESTRICTION;
DRUG MEGADOSE;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
HEART ARREST;
HEART DEATH;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
HYPERTENSION;
IMPAIRED GLUCOSE TOLERANCE;
ISCHEMIC HEART DISEASE;
LETTER;
MAJOR CLINICAL STUDY;
METABOLIC SYNDROME X;
NEW ONSET DIABETES;
ONSET AGE;
RANDOMIZED CONTROLLED TRIAL;
RESUSCITATION;
TREATMENT DURATION;
TRIACYLGLYCEROL BLOOD LEVEL;
CARDIOVASCULAR DISEASES;
CHEMICALLY INDUCED;
COMPLICATION;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PREDIABETIC STATE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 84921657213
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2014.10.053 Document Type: Letter |
|
Times cited : (38)
|
|
References (5)
|
